Francisco Javier
López González
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (13)
2019
-
BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice
Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368
-
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy
Epilepsy and Behavior, Vol. 97, pp. 51-59
-
Use of intravenous brivaracetam in status epilepticus: A multicenter registry
Epilepsia, Vol. 60, Núm. 8, pp. 1593-1601
2018
-
Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data
Epilepsia, Vol. 59, Núm. 9, pp. 1727-1739
-
Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study
Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752
2017
-
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series
Seizure, Vol. 48, pp. 53-56
-
Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)
Epilepsy Research
-
Eslicarbazepine acetate and carotid intima-media thickness in epileptic patients
Epilepsy Research, Vol. 138, pp. 81-87
2016
-
Guía oficial de la Sociedad Española de Neurología de práctica clínica en epilepsia
Neurologia, Vol. 31, Núm. 2, pp. 121-129
-
NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy
Epilepsy and Behavior, Vol. 65, pp. 25-32
-
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study
Epilepsy Research, Vol. 126, pp. 201-210
2015
-
Prognosis in epilepsy: Initiating long-term drug therapy
Neurologia, Vol. 30, Núm. 6, pp. 367-374
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218